XML 96 R60.htm IDEA: XBRL DOCUMENT v3.21.1
Caelum Biosciences - Net Assets Assumed (Details) - Variable Interest Entity, Primary Beneficiary
$ in Millions
Mar. 31, 2021
USD ($)
Noncontrolling Interest [Line Items]  
Cash and cash equivalents $ 16.9
In-process research & development assets (IPR&D) 193.3
Other assets and liabilities, net 6.8
Total net assets acquired $ 217.0